Accordingly, an ITPA polymorphism has been shown to correlate with levels of methylated thiopurine metabolites in 66 children with ALL [94], levels of 6-TG incorporation into DNA in 132 ALL patients, and is a factor highly likely to influence outcome of ALL patients treated with thiopurines [95]. Here, ITPA is linked to acute lymphoblastic leukemia.